Background and aim: Prisons in Egypt do not currently screen for blood-borne viruses, and there are no statistics concerning the prevalence of hepatitis C virus, hepatitis B virus or human immunodeficiency virus among prisoners. This study was performed to detect the prevalence of antibodies against hepatitis C, hepatitis B core and human immunodeficiency virus among Egyptian prisoners. Methods: The study was conducted in an Egyptian prison. The prisoners voluntarily completed a risk factor questionnaire and provided blood specimens for testing for antibodies against hepatitis C virus, hepatitis B virus core antigen and human immunodeficiency virus. Positive results were confirmed by the detecting HCV RNA via polymerase chain reaction. Multivariate regression analysis was performed to determine the factors that were independently associated with positive HCV serology. Results: Five hundred resident prisoners were screened. The prevalence of hepatitis C virus antibodies was 15.8% (79/500), and viremia was confirmed by PCR in 77.2% (61/79) of the antibody-positive prisoners. The prevalence of antibodies to hepatitis B core antigen was 9.8% (49/500), and 1.2% (6/500) of prisoners were dually infected with HBV and HCV. Antibodies to human immunodeficiency virus were not detected in any of the prisoners. The best predictor for hepatitis C and hepatitis B infection was a history of intravenous drug use (P < 0.011 for HBV and P < 0.001 for HCV), a period of >10 years spent in prison (P < 0.052 for HBV and P < 0.021 for HCV) and shared toiletries (P < 0.059 for HBV and P < 0.002 for HCV).
Introduction
The prevention of blood-borne pathogen transmission is a high priority for the Ministry of Health and Population (MOHP) in Egypt [1] . Despite the availability of several reports concerning anti-hepatitis C virus (HCV) seropositivity among apparently healthy Egyptian populations, little attention has been paid to the HCV and hepatitis B virus (HBV) burden of Egyptian prisoners.
HCV infection is highly endemic in Egypt; there is evidence of chronic HCV infection in 10-15% of the population [2] . Numerous studies have identified diverse risk factors associated with HCV transmission [3] .
Similar to HCV, there are few studies evaluating the risks associated with HBV transmission in Egypt. The epidemiology of HBV infections in Egypt has not been well characterized. Cross-sectional studies indicate that HBV is of intermediate endemicity, with 3-5% of the population chronically infected [4] .
The reported high prevalences of hepatitis C virus (HCV), hepatitis B virus (HBV) and human immunodeficiency virus (HIV) in prison populations is attributed to the disproportionate number of prisoners who engage in risky behavior, particularly intravenous drug users (IDUs). There are concerns that prisons could serve as reservoirs to amplify disease transmission to the wider community upon the release of inmates who became infected while incarcerated. Such reservoirs could be formed by the high prevalence of infections such as HIV, HBV and HCV among inmates, particularly those with a history of intravenous drug use [5] .
The effects of intra-prison disease transmission are not limited to those that are incarcerated, as the risk for continued transmission extends to the general community to which the ex-offender returns. Thus, interventions addressing the prevention of infections in prisons affect the larger community [6] .
Health care in Egyptian prisons is provided in an outpatient clinic by one general practitioner. Within 1 day of arrival, prisoners are medically examined, and those who are ill are directly admitted into the prison clinic. The living conditions are adequate with respect to sanitary facilities, water, light, ventilation, sleeping accommodations and food. There is no published data regarding the burden of HBV, HCV and HIV infection among prisoners in Egypt. To date, HCV, HBV and HIV testing has been implemented inside the prison only upon request. The practice of risky behavior, such as tattooing and sharing toiletries, occurs frequently during incarceration.
We conducted this study to determine the prevalence and behavioral correlates of HCV, HBV and HIV infections among Egyptian prisoners.
The identification of risk factors in this study and others can form the basis for developing a comprehensive strategy to prevent the transmission of blood-borne pathogens in prisons. The strategy should include a program that targets HBV prevention efforts, including vaccination for high-risk groups, raising public awareness and demands for safety and infection control standards in prisons.
Patients and methods
This study was conducted in one of the Egyptian prisons in the Minia governorate. Five hundred (109 females and 391 males) of the 1200 eligible inmates in the prison were studied. The inmates that participated in the study had been incarcerated for at least 24 months, and they were selected by random sampling. After obtaining written informed consent from each subject, a questionnaire was completed to gather information regarding sociodemographics, prison history and risk factors for HCV infection. Researchers met groups of 5 to 10 prisoners. The survey was explained, and prisoners were advised that the survey was voluntary and confidential. No incentives were offered. The prisoners who did not want to meet the researchers in a group setting were approached individually. A researcher assisted those with literacy difficulties.
The study was approved by the Prison Service Directorate of Health Care and the Research Ethics Committee of Mina University, Egypt.
Serological assay
Serum samples were tested for anti-HCV antibodies according to the manufacturer's instructions with a third-generation enzyme immunoassay (Cortez Diagnostics, California, USA).
Sera were tested for antibodies against the hepatitis B core (anti-HBc Ab) using the commercially available Diagnostics anti-HBc EIA enzyme-linked immunosorbent assay (DIASORIN, Italy). HIV serology was performed using Standard Diagnostic, Inc. (Kyonggi-do, Korea) and fluorescence assay (bio Mérieux S.A., France and bio Mérieux Vitek, Inc., USA).
Detection of hepatitis C by real-time PCR
Sera that tested positive for anti-HCV antibodies were further tested for HCV RNA. The RNA extraction was automated by a Qiacube instrument (Qiagen, Germany), and amplification was then performed by real-time PCR. PCR products were obtained using 25 L reactions (16.5 L master mix and 8. 
Clinical history and examination
The clinical history and examination was performed by a clinician and a well-trained ultrasonographer. Thorough clinical histories were taken and examinations were given for seropositive prisoners. For this, special emphasis was given to symptoms suggestive of chronic liver disease, such as fatigue, dyspepsia, fever, itching, change in the color of sclera and urine, abdominal pain, abdominal distension, swelling of lower limbs, hematemesis, melena, bleeding tendencies and a disturbed level of consciousness.
The general examination gave special emphasis to signs of chronic liver diseases, such as a disturbed level of consciousness, jaundice, scratch marks, pallor, gynecomastia, flapping tremors, palmer erythema, spider nevi, finger clubbing and edema of the lower limbs.
The abdominal examination emphasized abdominal contour, divarication of recti, subcostal angle, hair distribution and dilated veins. The liver was palpated to assess its size, surface, consistency, edge and tenderness. Percussion for ascites was performed.
The abdominal ultrasonography examination was performed to detect liver size, surface, echo pattern, hepatic focal lesions and portal vein diameter. Splenic size, splenic vein diameter and the presence of ascites were also reported.
Cirrhosis was diagnosed based on clinical, biochemical and imaging criteria. In this study, a decreased ALT/AST ratio, prolonged PT and thrombocytopenia were used to diagnose cirrhosis; this discriminated score was reported by Bonacini et al. [7] .
For patients with normal-or small-sized fatty liver, cirrhosis was diagnosed by ultrasound with one of the following: coarse, bright hepatic parenchyma or a caudate-to-right lobe ratio of >0.6 [8] .
Laboratory tests
Laboratory testing included serum ALT levels (up to 40 U/L), total bilirubin (0.1-1.0 mg/L), albumin (3.5-5.2 g/L), prothrombin time (11-12 s) and platelet counts (150-400 × 10 9 L −1 ).
Statistical analysis
The results were expressed as numbers (%). The comparison between the categorical data [n (%)] was performed using the Chi square test. The SPSS computer program (version 11 for Windows) was used for data analysis. Multivariate regression analysis was used to identify the factors associated with positive test results. A P value equal to or less than 0.05 was considered significant.
Results

Subject characteristics
During an 18-month period, a total of 500 prisoners gave written informed consent to participate in the study. The mean age of the prisoners included in the study was 41.0 ± 10.2 years (range: 28-62). Greater than 86% were married, 3.9% were single and 9.7% were divorced or widowed. Fourteen percent of the resident prisoners had been imprisoned previously, and their average time spent in prison was 12.4 (3.0-22) years. Greater than 40.2% of the prisoners performed manual labor, and only 1.4% worked in health care services ( Table 1 ).
The prevalence of viral antibodies
The prevalence rate of antibodies against hepatitis C virus was 15.8% (79/500). Among anti-HCV-positive subjects, 61 (12.2%) had viremia by PCR. The prevalence of antibodies against the hepatitis B core antigen was 9.8% (49/500), and co-infections with HCV and HBV were reported in 1.2% of subjects. HIV antibodies were not detected in any of the prisoners. The antibody prevalence rates by selected sociodemographic data are shown in Table 1 . The highest prevalences of HCV-Ab and HBc-Ab were recorded among the age group of greater than 45 years, and the lowest prevalences were identified among the age group of less than 30 years. The prevalences of HBc-Ab, HCV-Ab and dual infections were higher in males (83.7%, 82.0%, and 83.3%) than in females. The highest prevalences of HBc-Ab, HCVAb and dual infections were reported in resident prisoners who had spent more than 10 years in prison.
Multivariate regression analysis
Logistic regression models were constructed to clarify the associations between risky behavior and HBV and HCV infections ( Table 2 ). The most important predictors of hepatitis B core antigen and hepatitis C virus seropositivity were a history of intravenous drug use, an incarceration period of greater than 10 years, shared toiletries and diabetes mellitus (DM). Those who reported previous imprisonment, dental procedures, age greater than 45 years, tattooing and high BMI were more likely to be positive for antibodies to hepatitis C. There was no significant association between HCV or HBV infections with residence, age, job, gender, level of education or alcohol consumption. Most of the seropositive prisoners had evidence of chronic liver disease. The HCV-positive prisoners had significantly higher BMI, DM prevalence, ALT levels and thrombocytopenia compared to HBV-positive prisoners. However, there were no significant differences with respect to bilirubin or albumin levels and prothrombin time. Cirrhosis was detected in 8.2% of the prisoners positive for only anti-HBc antibodies. In comparison, cirrhosis was present in 18% of the prisoners with anti-HCV antibodies. HCV infection was more significantly associated with cirrhosis than HBV infection (Table 3) .
HCV RNA was detected by RT-PCR in 61 (77.2%) of the prisoners who were anti-HCV positive. Of these, 
Discussion
Despite the availability of several reports concerning anti-HCV seropositivity among apparently healthy Egyptian populations, such as workers traveling abroad [9] , blood donors [10] , military recruits [11] , rural primary school children and inhabitants of a rural village [12] , little attention has been paid to the burden of HCV and HBV infections among Egyptian prisoners. Therefore, this work is the first study to shed light on anti-HCV, anti-HBc and HIV seroprevalence and the factors associated with these infections among Egyptian prisoners. The HCV-Ab prevalence in this study was 15.8%, which is higher than that detected in the general population (14.7%) [13] .
Several studies have observed higher HCV prevalences in imprisoned populations. A study in a Brazilian female prison found an HCV seroprevalence of 16.2% [14] . An HCV seroprevalence range of 16-41% was identified in an incarcerated population in the USA, and approximately 12-35% of the prisoners had chronic hepatitis C [15] .
Our study reports a significant difference in HCV seroprevalence with respect to gender, with a higher prevalence in males. Ford et al. reported that the seroprevalence was 39.8% among the female inmates [16] , while other studies did not differentiate between male and female inmates [17] .
It has been reported that HCV RNA can be detected in 40-90% of subjects that are positive for HCV antibodies [13] . In our population, 61 (77.2%) of the inmates positive for HCV antibodies tested positive for HCV RNA. This information corroborates the hypothesis that prisoners are important carriers of HCV and are a potential source of transmission.
Future studies will have to investigate whether detecting HCV viremia for all incoming prisoners via routine HCV RNA testing will be useful. These studies should weigh the benefits of the potential prevention of HCV transmission and the possible therapeutic consequences against the significant costs of such a testing regimen [18] .
Approximately 10% of our prisoners had evidence of antibodies against the hepatitis B core antigen. The results of this study are in agreement with earlier studies by Schreiber et al., which reported that Egypt has an intermediate prevalence (2-8%) of HBV infection [19] . Our reported prevalence is also similar to those reported in Irish (8.7%) and United Kingdom (8%) prisons [20, 21] .
In contrast, the prevalence of HIV in our prison populations was zero. This may be an accurate reflection of the very low prevalence of HIV in the Egyptian population, with an estimated adult prevalence rate of less than 0.01% [22] .
Coexisting HCV and HBV infections have been estimated at 1.2% in our study. However, dual infections with HBV and HCV were detected in 10% of the Egyptian general population, while isolated anti-HBc, a marker of previous HBV exposure, was reported in 45% of chronic hepatitis C patients. This high figure for anti-HBc suggests a common route of transmission for both viruses [23] .
This study indicates that a history of intravenous drug use is the most important risk factor for both HBV and HCV infections. This result agrees with previous studies. Although both infections are prevalent among this risk group population, the impact of HCV infection is profound, and urgent intervention is required to curb drug abuse [24] [25] [26] . Weild et al. reported that the prevalence of anti-HCV among adult IDUs was 31%, while the prevalence of anti-HBc was 20%. Therefore, it is less likely, but not impossible, that this virus is transmitted in prison [21] .
In certain countries, successful educational programs have been developed to reduce the risk of hepatitis and HIV transmission among IDUs. In England and Wales, measures to reduce the spread of blood-borne virus infections in prisons include health promotion, vaccination against hepatitis B, a range of options for coming off drugs and methadone treatment for opiate withdrawal. The distribution of bleach tablets to disinfect injecting equipment was piloted in 1998. Bleach is an intervention for when IDUs have no safer alternative. The once-only use of sterile needles and syringes is considered to be the most effective preventive measure. The absence of needle exchanges within prisons puts IDU prisoners at a disadvantage compared to IDUs in the community [21] .
We identified an effect of tattooing on HCV seroprevalence. However, HBV infection was not significantly associated with tattooing. Tattooing is common in prison populations and, as reported elsewhere, seems to be associated with HBV and HCV infections. This is an important finding because there is poor general awareness of the risk of tattooing in Egypt. Studies that specified the venue of tattooing showed no definitive evidence for an increased risk of HCV infection when tattoos and piercings were received in professional parlors. However, the risk of HCV infection is significantly increased by tattooing, particularly among high-risk groups that receive tattoos in prison settings or by friends [27] .
It has been suggested that previous imprisonment is associated with HCV infection [28] . In our study, we reported a significant association by univariate analysis of previous imprisonment with positive HCV serology, but not HBV. A higher proportion of subjects with previous imprisonment were IDUs, likely explaining the higher HCV seroprevalence. This variable was also identified as an independent risk factor for HCV infection by Guimarães et al. [28] .
The participants who spent more time in prison over the previous 10 years and those who shared toiletries while in prison were significantly more likely to be positive for antibodies to HCV and HBV. Previous studies reported that individuals incarcerated for a longer time were 2.44 times more likely to be HCV-positive [29] . There was also clear evidence that equipment is frequently shared among inmates, and the risk of equipment contamination by parenterally transmitted viruses is higher within the prison system than outside of it. Measures to minimize the spread of hepatitis within prisons are essential. In addition, prison is an appropriate time for interventions by educating prisoners about the risks of hepatitis transmission and providing vaccinations [30] .
Our study reported that having a dental procedure was a significant independent risk factor for HCV infection. Lock et al. demonstrated that a considerable proportion of toothbrushes used by hepatitis C patients were contaminated with HCV RNA [31] . Egyptian patients with periodontal disease exhibited higher rates of anti-HCV and/or anti-HBc antibodies than the controls [32] .
Other proposed routes of transmission do not seem to be relevant in the studied population. All of the subjects denied a history of sharing needles and homosexuality. Some studies have stated that homosexuality leads to a greater chance of HCV infection. This association was not confirmed in our study [33, 34] . All of the subjects positive for HCV antibodies denied homosexual practices. This finding suggests that the association identified in other studies might be related to other risk behaviors rather than homosexuality itself, which is in accordance with Fox et al. [35] and Mahfoud et al. [36] .
Due to religious beliefs, abnormal sexual relationships are not common in the Egyptian community. Therefore, we suspected that we might receive non-truthful answers to this question. Nevertheless, all of the prisoners denied abnormal sexual behavior.
Being over 45 years of age was associated with positive serology for HCV, a finding that was also observed in other studies [37] [38] [39] . This may be explained by a higher risk of exposure to HCV over time.
DM was strongly associated with HC and HBV infections. The association of HCV and DM is complex, and some studies suggest that the higher prevalence of DM is a result of more severe liver disease in HCV-and HBV-infected groups [40] . Other studies have shown that a higher prevalence of DM in HCV-infected patients is attributable to a higher prevalence of DM in African Americans with HCV [41] .
The clinical course of liver disease was rather mild in our study. Approximately 15.8% of the prisoners were anti-HCV positive, and 77.2% had HCV viremia. This was compared to only 9.8% having anti-HBc antibodies, and the predominant potential cause of chronic liver diseases (CLD) was HCV infection. When the morbidity data were analyzed according to HCV and HBV infection status, DM was detected in 19.7% of HCV-infected individuals compared with 4.1% with HBV infection alone. However, other significant differences were observed between patients with HBV and HCV infections, such as elevated ALT levels, cirrhosis, high BMI and thrombocytopenia.
Strickland et al. reported that anti-HCV-positive case patients were more likely to have elevated ALT levels and ultrasound findings of cirrhosis. Consistent with previous reports, anti-HBc status was not statistically associated with cirrhosis, ALT, AST, albumin levels or platelet counts [42] .
In a case-control study by Andrew and collogues to determine the seroprevalence of HCV infection in a cohort of 594 diabetics, DM was observed in 21% of HCV-infected patients compared with 12% of HBV-infected subjects. Because there were significant differences between the HCV and HBV cohorts, no firm conclusions could be drawn from this analysis concerning the relative contribution of each variable to glucose intolerance [43] .
One of the important hematological findings in our study was thrombocytopenia, as 48.1% of HCV-positive prisoners had thrombocytopenia. Thrombocytopenia is not only important for HCV as a mere association but also because it has been proposed as a significant predictive indicator of esophageal varices in HCV patients [44] .
It was recommended that patients with lone thrombocytopenia should be screened for HCV, particularly in endemic areas or where blood and blood products are not properly screened [45] .
We observed that obesity was significantly more common among HCV-positive patients than hepatitis B-positive patients. This was in agreement with Chen et al., who reported that obesity may be more prevalent in people who test positive for HCV antibodies than in the general population. The presence of HCV viremia may be associated with an increased risk of obesity [46] .
HCV infection was more significantly associated with cirrhosis than HBV infection. The predominant potential cause of chronic liver disease was infection with HCV. Several other reports that confirmed low rates of cirrhosis in HCV patients highlighted the slow speed of disease progression [47] . Thus, large-scale interferon-based therapies for young men in prison may be needed to prevent severe liver disease. Additionally, successful antiviral therapy could prevent further HCV transmission.
The frequency of cirrhosis in this study was similar to other previously reported patient groups [10, 42] . However, our results might underestimate the frequency of cirrhosis, as diagnoses based on a clinical discriminate score are less sensitive than histopathologic diagnoses. Now is the time for policy makers, researchers and clinicians working in prisons to ensure that prison does not unnecessarily add to the health risks of this already disadvantaged population.
Limitations to this study must be considered. First, as only a single prison was included, the data are not representative of the entire Egyptian prison system, and a selection bias may have occurred. However, this bias was minimized by the broad geographic diversity of the selected prisoners. Secondly, the statuses of IDUs were determined by self-reporting, and prisoners may be reluctant to admit a history of use due to fear of possible consequences, such as additional punishment. Finally, the questionnaire did not address socioeconomic factors, such as income and education, which generally are good indicators of low awareness of viral disease transmission.
Despite these limitations, we can still conclude that there is a strong need for HCV care (i.e., testing and treatment) in prisons. The high intraprison prevalence of HBV underscores the need to vaccinate prison populations. Initiation of control measures to prevent continued transmission after incarceration should be undertaken.
